Ascendis Pharma A/S (ASND) Earnings Date, Estimates & Call Transcripts $148.88 +2.29 (+1.56%) (As of 09/18/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueASND Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ASND Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DarwinCurious About AI's Next Big Winners? 🚀Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.[Download Your Free Report Now] Ascendis Pharma A/S Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($2.16)($2.16)($2.16)Q2 20242($1.98)($1.07)($1.53)Q3 20242($1.96)($0.50)($1.23)Q4 20242($1.72)($0.17)($0.95)FY 20247($7.82)($3.90)($5.86)Q1 20251($1.56)($1.56)($1.56)Q2 20251($1.37)($1.37)($1.37)Q3 20251($1.11)($1.11)($1.11)Q4 20251($0.77)($0.77)($0.77)FY 20254($4.81)($4.81)($4.81) Get Ascendis Pharma A/S Earnings AlertsEnter your email address below to receive the latest news and earnings results for ASND and its competitors with MarketBeat's FREE daily newsletter. ASND Earnings Date and InformationAscendis Pharma A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.Read More Ascendis Pharma A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/5/2024(Estimated)------- 5/2/2024Q1 2024($1.57)($2.48)($0.91)($2.48)$85.72 million$103.11 million 2/7/2024Q4 2023($2.15)($1.66)+$0.49($1.66)$97.02 million$148.62 million 11/7/2023Q3 2023($2.63)($3.12)($0.49)($3.12)$52.54 million$52.02 million 9/5/2023Q2 2023($2.68)($2.35)+$0.33($2.35)$41.73 million$51.59 million4/27/2023Q1 2023($2.84)($2.12)+$0.72($2.12)$24.53 million$36.04 million 2/16/2023Q4 2022($2.50)($3.78)($1.28)($3.78)$20.31 million$23.38 million Get the Latest News and Ratings for ASND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022($2.52)($3.05)($0.53)($3.05)$10.67 million$15.41 million8/10/2022Q2 2022($2.11)($1.54)+$0.57($1.54)$7.07 million$6.51 million5/11/2022Q1 2022($2.25)($2.48)($0.23)($2.48)$5.89 million$7.66 million 3/2/2022Q4 2021($2.57)($2.14)+$0.43($2.14)$2.78 million$5.60 million 11/9/2021Q3 2021($2.60)($1.47)+$1.13($1.73)$1.60 million$1.31 million 8/24/2021Q2 2021($2.75)($2.50)+$0.25($3.01)$1.46 million$1.23 million 5/26/2021Q1 2021($2.06)($1.17)+$0.89($1.41)$1.94 million$0.90 million 3/9/2021Q4 2020($1.84)($2.64)($0.80)($3.15)$2.71 million$0.64 million 11/16/2020Q3 2020($1.57)($2.31)($0.74)($2.70)$1.94 million$3.22 million 8/27/2020Q2 2020($1.66)($1.97)($0.31)($2.17)$2.47 million$1.58 million 5/19/2020Q1 2020($1.43)($1.32)+$0.11($1.46)$2.66 million$2.45 million 4/1/2020Q4 2019($1.27)($1.88)($0.61)($1.88)-$2.78 million 11/18/2019Q3 2019($1.37)($0.59)+$0.78($0.59)$1.88 million$2.49 million Ascendis Pharma A/S Earnings - Frequently Asked Questions When is Ascendis Pharma A/S's earnings date? Ascendis Pharma A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on ASND's earnings history. How much revenue does Ascendis Pharma A/S generate each year? Ascendis Pharma A/S (NASDAQ:ASND) has a recorded annual revenue of $317.63 million. How much profit does Ascendis Pharma A/S generate each year? Ascendis Pharma A/S (NASDAQ:ASND) has a recorded net income of -$521.07 million. ASND has generated -$9.61 earnings per share over the last four quarters. What is Ascendis Pharma A/S's EPS forecast for next year? Ascendis Pharma A/S's earnings are expected to grow from ($6.83) per share to ($3.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BNTX Earnings Date TEVA Earnings Date BGNE Earnings Date GMAB Earnings Date SMMT Earnings Date VTRS Earnings Date RDY Earnings Date PCVX Earnings Date SRPT Earnings Date DNA Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:ASND) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascendis Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascendis Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASND Stock Alerts